Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2007
11/08/2007WO2007126792A2 Use of ghrelin splice variant for treating high cholesterol levels or high plasma glucose levels and releated diseases
11/08/2007WO2007126455A2 Method for using boc/cdo to modulate hedgehog signaling
11/08/2007WO2007126415A2 Novel compositions and methods for promoting, inhibiting, and detecting protein entry into cells
11/08/2007WO2007126392A1 Antimicrobial peptides
11/08/2007WO2007126365A2 Further medical uses of antisecretory protein
11/08/2007WO2007126363A2 Antisecretory protein for use in the treatment of compartment syndrome
11/08/2007WO2007126336A1 Agent exhibiting immunoregulatory properties and the use thereof for treating autoimmune diseases
11/08/2007WO2007126111A1 PEPTIDE CAPABLE OF INHIBITING AMYLOID-β FIBROSIS
11/08/2007WO2007125946A1 Peptide
11/08/2007WO2007125888A1 Liquid composition for oral dosage
11/08/2007WO2007125823A1 Composition comprising polysaccharide having immunomodulating function as main ingredient
11/08/2007WO2007125723A1 Glomerular slit protein inducer
11/08/2007WO2007125621A1 Novel use of gene whose expression is increased in hyperplastic pancreatic islet
11/08/2007WO2007125619A1 Novel compound having gpr54 agonistic activity
11/08/2007WO2007125226A2 Peptides modulating the activity of macrophages, useable for the treatment of rheumatoid arthritis
11/08/2007WO2007125210A2 Use of multivalent synthetic ligands of surface nucleolin for treating cancer or inflammation
11/08/2007WO2007125209A1 Novel polypeptides inducing dendritic cell migration, as well as medicines and pharmaceutical compositions containing same
11/08/2007WO2007125142A1 Antimicrobial linear peptides
11/08/2007WO2007124618A1 Insulin-like growth factor-enriched nano-products of hairy antler and process for preparation thereof
11/08/2007WO2007124541A1 Cox-2 inhibitor
11/08/2007WO2007109681A3 Compositions and methods for enhancing vasodilation
11/08/2007WO2007109609A8 Method for inhibiting angiogenesis
11/08/2007WO2007109118A3 RECOMBINANT HUMAN CC 10 (rhCC10) FOR TREATMENT OF RESPIRATORY DISORDERS
11/08/2007WO2007104768A3 Di-polymer protein conjugates and processes for their preparation
11/08/2007WO2007100628A9 Destruction of spores through glycoconjugate enhanced phagocytosis
11/08/2007WO2007100385A3 Macrocyclic depsipeptide antibody-drug conjugates and methods
11/08/2007WO2007099348A3 Cathepsin propeptide and uses thereof
11/08/2007WO2007088099A3 Compounds for the treatment of ischemia and neurodegeneration
11/08/2007WO2007086898A3 Methods and compositions related to anthrax spore glycoproteins
11/08/2007WO2007084460A3 Pharmaceutical compositions with enhanced stability
11/08/2007WO2007082052A3 Therapeutic compositions and methods useful in modulating protein tyrosine phosphatases
11/08/2007WO2007080400A3 Ace n-domain crystal
11/08/2007WO2007077465A3 Treatment of hiv
11/08/2007WO2007070850A3 Skin care compositions and treatments
11/08/2007WO2007066017A3 Method for preparing a factor h concentrate and the use thereof in the form of a drug
11/08/2007WO2007059435A9 Compositions and methods for enhancing cognitive function
11/08/2007WO2007044476A3 Lysozyme fortified milk and milk products
11/08/2007WO2007044413A3 Wwox gene, vectors containing the same, and uses in treatment of cancer
11/08/2007WO2007035828A3 Compositions and methods for preventing or treating encephalitis with interferon
11/08/2007WO2007031559A3 Human coagulation factor vii polypeptides
11/08/2007WO2007019522A3 Reversal of adult onset disorders with granulocyte-colony stimulating factors
11/08/2007WO2007009895A3 USE OF FACTOR VIIa OR FACTOR VIIa EQUIVALENTS FOR PREVENTING OR ATTENUATING HAEMORRHAGE GROWTH, AND/OR OEDEMA GENERATION FOLLOWING INTRACEREBRAL HAEMORRHAGE (ICH) IN PATIENTS TREATED WITH ANTIPLATELET THERAPY
11/08/2007WO2007005990A3 Cytoprotective thereapeutic agents for the prevention of reperfusion injury following ischemic stroke
11/08/2007WO2007004876A3 Peptides inhibiting angiotensin-converting enzyme
11/08/2007WO2006096690A3 Compositions and methods for inhibiting g protein signaling
11/08/2007WO2006059105A8 Non-cytotoxic protein conjugates
11/08/2007WO2005009394A3 Drug delivery in the nervous system
11/08/2007WO2002046458A9 Nucleic acids of the human abca5, abca6, abca9, and abca10 genes, vectors containing such nucleic acids and uses thereof
11/08/2007WO2002046220A9 Sequences upstream of the carp gene, vectors containing them and uses thereof
11/08/2007US20070259889 Protein Binding Compounds
11/08/2007US20070259844 Antiviral Compositions And Methods Of Using The Same
11/08/2007US20070259820 Methods and reagents for activating heat shock protein 70
11/08/2007US20070259819 Cosmetic Use of at Least Natural Tetrapeptide Ac-Ser-Asp-Lys-Pro or One of Its Analogs as a Skin Anti-Aging and Restructuring Agent
11/08/2007US20070259818 Methods and Compositions for Treating Conditions
11/08/2007US20070259817 CLK-peptide and SLK-peptide
11/08/2007US20070259816 Expression vector comprising nucleotide sequences coding homeobox gene for use in identifying modulators for treatment and prevention of nervous system and seizure disorders
11/08/2007US20070259815 Albumin fusion proteins
11/08/2007US20070259814 Platelet Derived Growth Factor and Methods of Use Thereof
11/08/2007US20070259813 Anti-Bacterial Composition Especially for Controlling Gram-Negative Bacteria, Comprising a Peptide and an Advantageously Hydrophobic Anti-Bacterial Agent
11/08/2007US20070259812 Peptide deformylase inhibitors as novel antibiotics
11/08/2007US20070259811 Method of modulating the proliferation of medullary thyroid carcinoma cells
11/08/2007US20070259810 Pharmaceutical compositions for lipophilic drugs
11/08/2007US20070259809 Methods of Using High Affinity Atiii Variants
11/08/2007US20070259808 Comprising hydrolyzed gelatin, tryptophan and ingestible carrier; for decubitus ulcers/bariatric surgery; made up of the essential amino acids
11/08/2007US20070259807 Growth Factor HTTER36
11/08/2007US20070259806 Brain-Associated Inhibitor of Tissue-Type Plasminogen Activator
11/08/2007US20070259805 Remedy For Melanoma
11/08/2007US20070259429 Adenoviral vectors having a protein IX deletion
11/08/2007US20070259422 isolated nucleic acid encoding an immunogenic peptide recognized by T lymphocytes; host cell transfected with the recombinant expression vector encoding an immunogenic protein; diagnosis of skin cancer; vaccine for prevention and treatment; immunotherapy
11/08/2007US20070259420 Modulating Photoreactivity in a Cell
11/08/2007US20070259419 CaM multi-functional protein kinase; for systematic study of the role of protein kinases in mammary gland development and carcinogenesis
11/08/2007US20070259417 Directed evolution of novel binding proteins
11/08/2007US20070259406 Antimicrobial Compounds
11/08/2007US20070259401 Single-chain polypeptide fusion comprising functional binding, translocation and clostridial neurotoxin heavy chain domain for use as therapeutic agents and/or transporter molecules
11/08/2007US20070259400 Antibodies
11/08/2007US20070259390 High throughput sarcomeric assay
11/08/2007US20070259383 Novel Genes involved in Epidermal differentiation, and uses thereof
11/08/2007US20070259379 Regulation of glucose and insulin levels by gnt-4 glycosyltransferase activity
11/08/2007US20070259378 For drug screening; competitive binding; measuring activation by measuring [Ca2+] in the mixture
11/08/2007US20070259358 which promote strand transfer activity of viral integrase, such as HIV integrase; screening molecules for antiviral activity comprising exposing the molecules to epithelial growth factors, fragments or nucleotides codes and determining the ability to modulate the interaction with retroviral integrases
11/08/2007US20070259087 Antimicrobial Peptides
11/08/2007US20070259053 Inhibition of nephrotoxicity induced by Trasylol® and like agents
11/08/2007US20070259050 Combined Cosmetic or Therapeutic Preparation
11/08/2007US20070259047 Protein Sustained-Release Microparticle Preparation for Injection and Process for Producing the Same
11/08/2007US20070259046 Process for removal of solvents from bead polymers
11/08/2007US20070259044 Compositions comprising biomembrane sealing agent for treatment of neuronal injury, and methods of use
11/08/2007US20070259036 Lactic acid polymer and process for producing the same
11/08/2007US20070259034 Highly absorbable coenzyme q10 composition and method of producing same
11/08/2007US20070259031 Central nervous system disorders such as cancer or neurodegenerative disorders; synthetic carrier such as liposome; Convection-enhanced delivery (CED) is a promising technique for local delivery of therapeutics that overcomes some of the limitations inherent in diffusion-based delivery
11/08/2007US20070259030 Methods, systems and reagents for tendon and ligament therapy
11/08/2007US20070259024 Composition and Method for Prevention or Treatment of Stomatitis
11/08/2007US20070259023 Insulin compensated nutrition
11/08/2007US20070259021 Compositions, Methods, and Kits for Treating Dry Eye
11/08/2007US20070259019 Implant depots to deliver growth factors to treat osteoporotic bone
11/08/2007US20070259018 Implant depots to deliver growth factors to treat avascular necrosis
11/08/2007US20070259014 Compositions for and Methods for Treating Hiv
11/08/2007US20070259005 Method of treating cancer
11/08/2007US20070259003 Clostridial toxin derivatives and methods for treating pain
11/08/2007US20070259002 Botulinum Toxin Therapy of Heart Rhythm Disorders
11/08/2007US20070258996 Synergistic combination of three or more of sequestering agents, carbohydrates, terpenes or terpenoids, amines, plant-derived oils, sulfonates, phenols, fatty acids, dibenzofuran derivatives, organo isothiocyanates, quaternary ammonium compounds, peroxides or macrolide polyenes; antiobiotic resistance
1 ... 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 ... 3163